Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis
Soheil Hassanipour, Hamed Delam, Morteza Arab‐Zozani, Elham Abdzadeh, Seyyed Ali Hosseini, Hossein‐Ali Nikbakht, Mahdi Malakoutikhah, Mohammad Taghi Ashoobi, Mohammad Fathalipour, Hamid Salehiniya, Shirin Riahi
Abstract
Background: Prostate cancer is one of the most common health issues among men, especially older men. In recent years, incidences of prostate cancer is increasing. Objective: The aim of this study was to provide a comprehensive estimate of the survival of prostate cancer in Asian countries. Methods: We searched five international databases including Medline/PubMed, Scopus, Embase, Web of Knowledge and ProQuest until June 1, 2018. The Newcastle-Ottawa Quality Assessment was used to evaluate the quality of selected papers. The review protocol was registered in PROSPERO (CRD42019117044). Results: A total of 714 titles were retrieved. Thirty-seven studies met the inclusion criteria. Based on the random-effect model one-year, five-year and ten-year survival rate of prostate cancer were 81% (95% CI 77.8-84.2), 61.9% (95% CI 59.5-64.3) and 36.2% (95% CI 9.2-63.2) respectively. Survival rates based on HDI level for five-year were 30.07, 43.43 and 70.84 percent for medium, high and very high levels, respectively. Conclusion: According to the results of our study, the prostate cancer survival rate in Asian countries is relatively lower than in Europe and North America.